
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
PHARMASEAL has announced a second major release of its Engility CTMS platform with new features like site monitoring and global access management.
Find out more about the new features






